CalciMedica is trading 5.7% lower at $1.65, with no clear company-specific catalyst identified for the September 28 decline.
- The company’s investor-relations page lists September 8 as its latest release.
- Renewed U.S.-Iran tensions have lifted oil prices and Treasury yields, reviving inflation concerns. Reuters reported global stocks fell amid the stalemate and higher-for-longer rate expectations; no direct link to CalciMedica’s move was reported.